Patent · US Expired

Identification of polymorphisms in the PCTG4 region of Xq13

US6566061B1 · kind B1 · utility

2Cited by
0References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 26, 2000
Grant dateMay 20, 2003
Priority date
Expiry dateJan 26, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Nucleic acid sequences within the q13 region of the X chromosome having polymorphisms associated with neuropsychiatric disorders and associated conditions are disclosed herein. One polymorphism occurs within the coding region of the HOPA gene and introduces a four amino acid insertion into a putative OPA domain, a domain which has been shown to be involved in tissue specific expression. Compositions including nucleic acids having these polymorphisms and antibodies to polymorphic regions within proteins encoded in the PCTG4 region are provided. Methods of using the information and nucleic acid sequences disclosed herein for the diagnosis and assessment of pathologies associated with neuropsychiatric disorders and associated conditions are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.